| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | RAF265 | CTRPv2 | pan-cancer | AAC | -0.05 | 0.2 |
| mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | AT7867 | CTRPv2 | pan-cancer | AAC | -0.042 | 0.2 |
| mRNA | BRD-K48334597 | CTRPv2 | pan-cancer | AAC | 0.083 | 0.2 |
| mRNA | PF-543 | CTRPv2 | pan-cancer | AAC | 0.045 | 0.2 |
| mRNA | GSK4112 | CTRPv2 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | Vorinostat | CTRPv2 | pan-cancer | AAC | 0.039 | 0.2 |
| mRNA | SB-743921 | CTRPv2 | pan-cancer | AAC | 0.038 | 0.2 |
| mRNA | navitoclax:PLX-4032 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.041 | 0.2 |
| mRNA | KU 0060648 | CTRPv2 | pan-cancer | AAC | -0.041 | 0.2 |